Trials / Completed
CompletedNCT02950922
Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 157 (actual)
- Sponsor
- Dermavant Sciences GmbH · Industry
- Sex
- All
- Age
- 12 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, randomized, vehicle-controlled, double-blind Phase 2 study in adults and adolescent subjects with mild to moderate atopic dermatitis.
Detailed description
The purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics of the 0.2% BID and 0.5% concentrations of RVT-501 in patients with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RVT-501 0.2% ointment | |
| DRUG | RVT-501 0.5% ointment | |
| OTHER | Vehicle ointment | Placebo comparator |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-07-03
- Completion
- 2017-07-03
- First posted
- 2016-11-01
- Last updated
- 2018-08-06
Locations
20 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02950922. Inclusion in this directory is not an endorsement.